Mesa Laboratories logo
Mesa Laboratories
MLAB | NASDAQ
Chart Builder DCF Calculator
$134.09
-$4.92 (-3.54%)
At close: Nov 16, 2026, 4:00 PM ET
$134.09
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Mesa Laboratories Company Profile

Company profile explained

Company Profile

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Key Executives

Name Position
Siddhartha Chandrakant Kadia Chief Executive Officer, President & Director
Brian David Archbold Senior Vice President of Operations & Continuous Improvement
John V. Sakys VP & CFO
Lyndsey Crennen Chief Accounting Officer

Latest SEC Filings

Date Type Title
Oct 29, 2026 4 Filing
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 13, 2026 8-K Current Report
Oct 09, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
Sep 11, 2026 4 Filing
View All SEC Filings ➞
Mesa Laboratories
Mesa Laboratories logo
Country United States
IPO Date Feb 29, 1984
Industry Medical - Specialties
Sector Healthcare
Employees 717
CEO Siddhartha C. Kadia

Contact Details

12100 West Sixth Avenue Lakewood, Colorado 80228 United States

Stock Details

Ticker Symbol MLAB
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000724004
CUSIP Number 59064R109
ISIN Number US59064R1095
SIC Code 3823

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.